Publications Breadcrumb Home Publications Since we carefully research publications with DZIF affiliation before posting them on the DZIF website, there is usually a delay of two to three months between a paper's publication date and its listing on the DZIF publications website. Show filterHide filter All years of publication All years of publication20122013201420152016201720182019202020212022202320242025 All research areas All research areasCommunity-Acquired Infections at Mucosal InterfacesHepatitisHIVInfections of the Immunocompromised HostHealthcare-Associated InfectionsMalaria and Neglected Tropical DiseasesEmerging InfectionsNovel AntibioticsTuberculosis All infrastructures All infrastructuresBioresources, Biodata and Digital HealthDZIF AcademyClinical Trial UnitProduct Development Apr 2021 Liver Int The impact of hepatitis B surface antigen on natural killer cells in patients with chronic hepatitis B virus infection Autoren Du Y et al. Apr 2021 Eur J Cancer 2021 update of the AGIHO guideline on evidence-based management of COVID-19 in patients with cancer regarding diagnostics, viral shedding, vaccination and therapy Autoren Giesen N et al. Apr 2021 Nature Bacterial peptides presented on tumour cells could be immunotherapy targets Autoren Riemer AB Apr 2021 Algal Research Biological and chemical characterization of new isolated halophilic microorganisms from saltern ponds of Trapani, Sicily Autoren Villanova V et al. Apr 2021 Emerg Infect Dis COVID-19-associated pulmonary aspergillosis, March-August 2020 Autoren Salmanton-García J et al. Apr 2021 Cancers (Basel) Efficacy and Safety of Checkpoint Inhibitor Treatment in Patients with Advanced Renal or Urothelial Cell Carcinoma and Concomitant Chronic Kidney Disease: A Retrospective Cohort Study Autoren Seydel F et al. Apr 2021 Vaccines (Basel) Efficacy of Birth Dose Vaccination in Preventing Mother-to-Child Transmission of Hepatitis B: A Randomized Controlled Trial Comparing Engerix-B and Sci-B-Vac Autoren Safadi R et al. Apr 2021 Am J Physiol Lung Cell Mol Physiol Immunoglobulin deficiency as an indicator of disease severity in patients with COVID-19 Autoren Husain-Syed F et al. Apr 2021 Int J Tuberc Lung Dis Impact of lung function on treatment outcome in patients with TB Autoren Chesov D et al. Apr 2021 Lancet Glob Health Lassa fever outcomes and prognostic factors in Nigeria (LASCOPE): a prospective cohort study Autoren Duvignaud A et al. Apr 2021 mBio Multiple Viral microRNAs Regulate Interferon Release and Signaling Early during Infection with Epstein-Barr Virus Autoren Bouvet M et al. Apr 2021 Int J Med Microbiol Recent advances in culture-based gut microbiome research Autoren Hitch TCA et al. Apr 2021 mBio Regulation of the Mitochondrion-Fatty Acid Axis for the Metabolic Reprogramming of Chlamydia trachomatis during Treatment with β-Lactam Antimicrobials Autoren Shima K et al. Apr 2021 Int J Med Microbiol The role of the blood group-related glycosyltransferases FUT2 and B4GALNT2 in susceptibility to infectious disease Autoren Galeev A et al. Mar 2021 Cell Rep Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication Autoren Garcia G Jr. et al. Mar 2021 Nat Genet Gain-of-function variants in SYK cause immune dysregulation and systemic inflammation in humans and mice Autoren Wang L et al. Mar 2021 J Med Chem Distinct Lugdunins from a New Efficient Synthesis and Broad Exploitation of Its MRSA-Antimicrobial Structure Autoren Saur JS et al. Mar 2021 Open Forum Infect Dis Dysregulated Host Response in Severe Acute Respiratory Syndrome Coronavirus 2-Induced Critical Illness Autoren Tiwari-Heckler S et al. Mar 2021 Bioorg Med Chem Lett Identification of non-covalent SARS-CoV-2 main protease inhibitors by a virtual screen of commercially available drug-like compounds Autoren Zhang L et al. Mar 2021 Life Sci Alliance DGCR8 deficiency impairs macrophage growth and unleashes the interferon response to mycobacteria Autoren Killy B et al. Mar 2021 J Clin Virol Impaired performance of SARS-CoV-2 antigen-detecting rapid diagnostic tests at elevated and low temperatures Autoren Haage V et al. Mar 2021 Nat Commun N-protein presents early in blood, dried blood and saliva during asymptomatic and symptomatic SARS-CoV-2 infection Autoren Shan D et al. Mar 2021 Nature Auto-aggressive CXCR6(+) CD8 T cells cause liver immune pathology in NASH Autoren Dudek M et al. Mar 2021 BMC Infect Dis Invasive aspergillosis in solid organ transplant patients: diagnosis, prophylaxis, treatment, and assessment of response Autoren Neofytos D et al. Mar 2021 Nature NASH limits anti-tumour surveillance in immunotherapy-treated HCC Autoren Pfister D et al. Pagination Previous page ‹‹ Seite 152 Seite 153 Seite 154 Seite 155 Current page 156 Seite 157 Seite 158 Seite 159 Seite 160 Seite 152 Seite 153 Seite 154 Seite 155 Seite 156 Seite 157 Seite 158 Seite 159 Seite 160 Next page ››
Apr 2021 Liver Int The impact of hepatitis B surface antigen on natural killer cells in patients with chronic hepatitis B virus infection Autoren Du Y et al.
Apr 2021 Eur J Cancer 2021 update of the AGIHO guideline on evidence-based management of COVID-19 in patients with cancer regarding diagnostics, viral shedding, vaccination and therapy Autoren Giesen N et al.
Apr 2021 Nature Bacterial peptides presented on tumour cells could be immunotherapy targets Autoren Riemer AB
Apr 2021 Algal Research Biological and chemical characterization of new isolated halophilic microorganisms from saltern ponds of Trapani, Sicily Autoren Villanova V et al.
Apr 2021 Emerg Infect Dis COVID-19-associated pulmonary aspergillosis, March-August 2020 Autoren Salmanton-García J et al.
Apr 2021 Cancers (Basel) Efficacy and Safety of Checkpoint Inhibitor Treatment in Patients with Advanced Renal or Urothelial Cell Carcinoma and Concomitant Chronic Kidney Disease: A Retrospective Cohort Study Autoren Seydel F et al.
Apr 2021 Vaccines (Basel) Efficacy of Birth Dose Vaccination in Preventing Mother-to-Child Transmission of Hepatitis B: A Randomized Controlled Trial Comparing Engerix-B and Sci-B-Vac Autoren Safadi R et al.
Apr 2021 Am J Physiol Lung Cell Mol Physiol Immunoglobulin deficiency as an indicator of disease severity in patients with COVID-19 Autoren Husain-Syed F et al.
Apr 2021 Int J Tuberc Lung Dis Impact of lung function on treatment outcome in patients with TB Autoren Chesov D et al.
Apr 2021 Lancet Glob Health Lassa fever outcomes and prognostic factors in Nigeria (LASCOPE): a prospective cohort study Autoren Duvignaud A et al.
Apr 2021 mBio Multiple Viral microRNAs Regulate Interferon Release and Signaling Early during Infection with Epstein-Barr Virus Autoren Bouvet M et al.
Apr 2021 Int J Med Microbiol Recent advances in culture-based gut microbiome research Autoren Hitch TCA et al.
Apr 2021 mBio Regulation of the Mitochondrion-Fatty Acid Axis for the Metabolic Reprogramming of Chlamydia trachomatis during Treatment with β-Lactam Antimicrobials Autoren Shima K et al.
Apr 2021 Int J Med Microbiol The role of the blood group-related glycosyltransferases FUT2 and B4GALNT2 in susceptibility to infectious disease Autoren Galeev A et al.
Mar 2021 Cell Rep Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication Autoren Garcia G Jr. et al.
Mar 2021 Nat Genet Gain-of-function variants in SYK cause immune dysregulation and systemic inflammation in humans and mice Autoren Wang L et al.
Mar 2021 J Med Chem Distinct Lugdunins from a New Efficient Synthesis and Broad Exploitation of Its MRSA-Antimicrobial Structure Autoren Saur JS et al.
Mar 2021 Open Forum Infect Dis Dysregulated Host Response in Severe Acute Respiratory Syndrome Coronavirus 2-Induced Critical Illness Autoren Tiwari-Heckler S et al.
Mar 2021 Bioorg Med Chem Lett Identification of non-covalent SARS-CoV-2 main protease inhibitors by a virtual screen of commercially available drug-like compounds Autoren Zhang L et al.
Mar 2021 Life Sci Alliance DGCR8 deficiency impairs macrophage growth and unleashes the interferon response to mycobacteria Autoren Killy B et al.
Mar 2021 J Clin Virol Impaired performance of SARS-CoV-2 antigen-detecting rapid diagnostic tests at elevated and low temperatures Autoren Haage V et al.
Mar 2021 Nat Commun N-protein presents early in blood, dried blood and saliva during asymptomatic and symptomatic SARS-CoV-2 infection Autoren Shan D et al.
Mar 2021 Nature Auto-aggressive CXCR6(+) CD8 T cells cause liver immune pathology in NASH Autoren Dudek M et al.
Mar 2021 BMC Infect Dis Invasive aspergillosis in solid organ transplant patients: diagnosis, prophylaxis, treatment, and assessment of response Autoren Neofytos D et al.
Mar 2021 Nature NASH limits anti-tumour surveillance in immunotherapy-treated HCC Autoren Pfister D et al.
